Select Page

Pioneering biotherapeutic delivery for the prevention and treatment of chronic lung disease

The matrikine PGP as a potential biomarker in COPD (2015)

The lack of a well-characterized biomarker for the diagnosis of chronic obstructive pulmonary disease (COPD) has...

The Airway Microbiome at Birth (2016)

Alterations of pulmonary microbiome have been recognized in multiple respiratory disorders. It is critically important...

Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia (2018)

The pathogenesis of bronchopulmonary dysplasia (BPD) is not well understood. We previously identified differences in...

Neutrophilic inflammation during lung development disrupts elastin assembly and predisposes adult mice to COPD (2021)

Emerging evidence indicates that early life events can increase the risk for developing chronic obstructive pulmonary...

Proven Pathways

Alveolus Bio is building on over a decade of research to develop breakthrough therapeutics that break the cycle of inflammation in chronic lung disease.

 

Pharmaceutical
Pipeline


Alveolus Bio is developing breakthrough therapeutics that specifically target
lung diseases.

About Us

Alveolus Bio is an interdisciplinary team of physicians, researchers, and innovators collaborating at the intersection of respiratory medicine and microbiome science.

C Vivek Lal MD FAAP

C Vivek Lal MD FAAP

Founder & CEO

Amit Gaggar MD PhD

Amit Gaggar MD PhD

Chief Medical Officer

Theodora Nicola MD PhD MBA

Theodora Nicola MD PhD MBA

Lead Scientist

Andrew O'Connor MS MBA

Andrew O'Connor MS MBA

COO

Maggie Belshé

Maggie Belshé

EVP, Marketing

Nancy Wenger

Nancy Wenger

Research and Development Manager

About Us

Yvonne Huang MD

Yvonne Huang MD

Science Advisor, Microbiome and Adult Lung Disease

Mike Wells MD PhD

Mike Wells MD PhD

Science Advisor, Clinical Trials and Adult Lung Disease

Nirmal Sharma MD

Nirmal Sharma MD

Science Advisor, Lung Transplant

Alveolus Bio is an interdisciplinary team of physicians, researchers, and innovators collaborating at the intersection of respiratory medicine, microbiome science, drug delivery modalities.

Namasivayam Ambalavanan MD

Namasivayam Ambalavanan MD

Science Advisor, Pediatric Lung Disease

Casey Morrow PhD

Casey Morrow PhD

Science Advisor, Microbiome

Art Tipton PhD

Art Tipton PhD

Industry Advisor

Join us in revolutionizing the standard of care 
for chronic respiratory diseases.